FDA issues strong warning about oral ketoconazole Clinical Endocrinology News Digital Network Because oral ketoconazole has been associated with hepatoxicity that can result in liver transplantation or death, it is now contraindicated in patients with acute or chronic liver disease. The label also now recommends that patients be assessed and ... |
